Study details
Enrolling now
Pelashield™ PainGuard™ vs Restrata® in HS Surgery
Rutgers, The State University of New Jersey
NCT IDNCT07316192ClinicalTrials.gov data as of Apr 2026
Target enrollment
10
Study length
about 10 months
Ages
18+
Locations
1 site in NJ
What this study is about
Researchers are testing if Pelashield™ PainGuard™, a new wound dressing, helps patients heal better after surgery for Hidradenitis Suppurativa (HS) compared to the current standard treatment, Restrata®. The trial will compare how quickly healthy tissue forms, when the wound is ready for graft placement, infection rates, and pain medication needs in both groups of patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Pelashield Painguard
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.